Literature DB >> 36157619

Red Desaturation Prevalence and Severity in Healthy Patients.

Brian Mikolajczyk1, Andrew Ritter1, Christian Larson1, John Connett1, Joshua Olson1, Collin McClelland1, Michael S Lee1.   

Abstract

Background and
Objectives: To determine the percentage of the healthy population that responds asymmetrically to the red desaturation test and to approximate the degree of red desaturation in those individuals. We also sought to elucidate any correlation between demographic variables and red desaturation prevalence and severity.
Methods: Adults aged 18 years and older with a normal eye examination, including confrontation fields and best-corrected visual acuity of ≥20/25 in both eyes, were eligible for this prevalence study. Those with objective or subjective afferent visual dysfunction were excluded. A total of 101 eligible participants (68.3% female and 31.7% male; racial/ethnic breakdown of 77.2% White, 11.9% Black, 8.9% Asian, 2.0% N/A; mean (SD) age: 41.5 (15.3) years) were queried whether the monocular perception of redness of a standardized tropicamide bottle cap was the same and to estimate the interocular percentage difference, with 1 eye perceiving the bottle cap at "100% redness."
Results: Twenty-four participants (23.8%) experienced some degree of red desaturation. For these individuals with red desaturation, the average interocular difference was 9.0% (range 2%-25%, 95% confidence interval 6.0%-12.0%). There was no statistical evidence for a relationship between red desaturation and race, sex, or age. Discussion: This study shows that nearly a quarter of healthy patients without apparent optic nerve or macular dysfunction may recognize red desaturation. This deserves consideration when interpreting red desaturation testing in patients suspected to have unilateral optic neuropathy. Further research with larger sample sizes may identify predictors of red desaturation in healthy patients, establish the red desaturation threshold separating pathologic from physiologic phenomena, and assess the repeatability of red desaturation over time in affected individuals.
© 2021 American Academy of Neurology.

Entities:  

Year:  2022        PMID: 36157619      PMCID: PMC9491505          DOI: 10.1212/CPJ.0000000000001011

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  2 in total

1.  The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1991-12

2.  A simple computer program to quantify red desaturation in patients with optic neuritis.

Authors:  Yehoshua Almog; Raz Gepstein; Arie Y Nemet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-19       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.